Showing results (2081-2090 of 2,232) with videos related to

Sort By:
Pageof 224
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
The Journal of Infection|February 11, 2023
HTLV seroprevalence in people using HIV pre-exposure prophylaxis in EnglandDaniel Bradshaw, Arham Khawar, Poorvi Patel, et al.
Nature Communications|November 14, 2023
Multiplexed detection of viral antigen and RNA using nanopore sensing and encoded molecular probesRen Ren, Shenglin Cai, Xiaona Fang, et al.
Frontiers in Endocrinology|December 3, 2021
Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 DiabetesLucas H Armitage, Scott E Stimpson, Katherine E Santostefano, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseRobert B Perni, Susan J Almquist, Randal A Byrn, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Carboxylate bioisosteres of pregabalinJacob B Schwarz, Norman L Colbry, Zhijian Zhu, et al.
AIDS Research and Human Retroviruses|October 28, 2006
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM)Carlos M De Castro-Costa, Abelardo Q C Araújo, Márcio M Barreto, et al.
Science (New York, N.Y.)|March 15, 2014
Complement is activated by IgG hexamers assembled at the cell surfaceChristoph A Diebolder, Frank J Beurskens, Rob N de Jong, et al.
Pageof 224